HealthPlix

AI-powered EMR that provides clinical decision support to doctors at the point of care.

Positions itself as India's largest EMR platform, usable both online and offline.

Built around a doctor-first philosophy rather than hospital- or payer-first design.

Individual doctors and clinics using HealthPlix's EMR & clinic-management software suite.

Hospitals using HealthPlix's hospital management solutions (H.A.L.O, IPD, PlixConnect).

Pharma companies using HealthPlix for doctor engagement and real-world-evidence data.

End patients of doctors on the HealthPlix network, served via the Patient App, which offers appointment booking, doctor chat, vitals tracking, and digital medical records.

Higher-paying 'Elite' subscribers get a named Dedicated Relationship Manager and satellite-clinic support, while the base 'Pro' tier gets standard support -- a relationship model segmented by plan.

New doctors get hands-on training from the HealthPlix team and can be live on the EMR within a day of registering.

Separate toll-free lines and an email desk serve doctors and patients respectively, positioned as continuously available for assistance.

Patients get a limited number of free doctor-chat messages after a visit, with paid options for further consultation -- a self-service, usage-metered relationship.

HealthPlix acquires doctors mainly through its own sales organization; its 2023 Series C round earmarked most of the new capital for scaling sales, product and engineering teams to grow the doctor base.

Prospective doctors and clinics can request a live walkthrough of the EMR directly through the HealthPlix website before purchasing.

Patients reach their HealthPlix-network doctors through dedicated native apps distributed on the Apple App Store and Google Play.

Pharma brands reach prescribing doctors directly inside the HealthPlix EMR workflow via the Robin ad platform, rather than solely through traditional field-rep visits.

Continuous R&D on the assistive-AI EMR so doctors can complete prescriptions and records in seconds rather than minutes, across 16+ specialties and 14 regional languages.

A dedicated function runs RWE studies, primary market research and post-market surveillance for pharma clients and manages end-to-end medical publications drawing on the doctor network's data.

A sales and customer-success operation recruits new doctors and gets them live on the platform, with hands-on training delivered within 24 hours of sign-up.

Separately from the doctor EMR, HealthPlix builds and operates AI transcription, inpatient-management and patient-engagement products built specifically for hospitals.

HealthPlix's core asset is the clinical data generated by a large, highly engaged doctor base -- the same network that powers its EMR, hospital tools and pharma-insights businesses.

An in-house-built, AI-assisted EMR platform underpins every product line, providing clinical decision support at the point of care.

Founder & CEO Sandeep Gudibanda previously co-founded dialysis-chain operator Nephroplus, bringing direct healthcare-delivery experience to HealthPlix's leadership.

HealthPlix has raised roughly $44.68Mn+ in institutional venture funding through its Series C round, capital that funds its technology and sales buildout.

Co-led HealthPlix's $22M Series C round (announced March 2023), structured as $20M in equity and $2M in venture debt.

Lightspeed Venture Partners, JSW Ventures, Kalaari Capital, Chiratae Ventures and venture-debt firm Blacksoil Capital all returned to participate in the Series C round.

Doctors and clinics pay a flat annual subscription for the EMR software, with two published tiers -- Pro and Elite -- differentiated by 'Plix Credits' allowance and support level.

HealthPlix sells pharma companies point-of-care advertising (Robin), real-world-evidence dashboards (Darwin), medical-publication support, primary market research and post-market surveillance -- monetizing its doctor/patient data network.

Hospitals separately license HealthPlix's AI transcription tool (H.A.L.O), inpatient-department management (IPD) and the PlixConnect patient-engagement platform.

Total expenses were Rs57.4 Cr in FY25 against revenue of Rs38.4 Cr+, per financials sourced from regulatory filings.

The gap between revenue and its cost base left HealthPlix with an estimated FY25 EBITDA of about Rs-18.2 Cr and a net loss of Rs19.0 Cr, roughly a -49% net margin.